Vimarsana
Biggest News Aggregation in the World

Page 13 - Sarcoma Foundation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sarcoma Foundation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sarcoma Foundation Today - Breaking & Trending Today

Adaptimmune Therapeutics PLC: Clinical Responses Reported across Patient Subgroups with Adaptimmune's Cell Therapy, Afami-cel, Confirming Potential for People with Rare Sarcomas - Vimarsana News

Adaptimmune Therapeutics PLC: Clinical Responses Reported across Patient Subgroups with Adaptimmune's Cell Therapy, Afami-cel, Confirming Potential for People with Rare Sarcomas

- Patients who responded to afami-cel had longer progression-free survival (median 58 weeks) compared to non-responders (median 12 weeks) -- Responses occurred across subgroups, with greater response

Leslie Marie Rowe - Vimarsana News

Leslie Marie Rowe

Leslie Marie Rowe, age 60, surrounded by her family, went to her Lord and Savior on Dec. 1, 2021, in Jacksonville, Florida.

Trey Lance, 49ers O-Line Attend Premiere of Trent Williams' Emotional Documentary - Vimarsana News

Trey Lance, 49ers O-Line Attend Premiere of Trent Williams' Emotional Documentary

Williams hosted a private screening for friends, family and teammates for his long-awaited documentary "Silverback: The Trent Williams Story."

Source: 49ers.com
Two-drug combo starves bone cancer cells to death - Vimarsana News

Two-drug combo starves bone cancer cells to death

Starving cancer cells of the energy they need to grow could one day provide an alternative to a commonly used chemotherapy drug without the risk of severe side effects, according to a new study. Studying human cancer cells and mice, researchers report that a two-drug combination targeting a tumor’s energy sources could prove as effective and less toxic than methotrexate, a long-used chemotherapy drug often given in high doses to treat osteosarcoma, a bone cancer. Osteosarcoma is the most common tumor of the bone in adults and children. It accounts for about 4% of all pediatric cancers and m...

Nixing bone cancer fuel supply offers new treatment approach, mouse study suggests | The Source - Vimarsana News

Nixing bone cancer fuel supply offers new treatment approach, mouse study suggests | The Source

Two drugs targeting cancer cells’ energy source potentially could replace toxic chemo in osteosarcoma January 26, 2021 SHARE A new study from Washington University School of Medicine in St. Louis suggests that a two-drug combination targeting a tumor’s energy sources could be as effective and less toxic than methotrexate, a long-used chemotherapy drug often given in high doses to treat osteosarcoma, a bone cancer. Shown is a cross section of osteosarcoma. (Image: Richa Rathore) An innovative approach to treating bone tumors — starving cancer cells of the energy they need to grow ...

Source: wustl.edu